Clinical Trial

Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy

Name: Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy — clinical trial record (NCT07145268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HBV

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to investigate the possible safety and efficacy of Zinc sulphate as antifibrotic agent in chronic HBV patient receiving antiviral therapy.

Trial Details

NCT Number	NCT07145268
Lead Sponsor	Tanta University
Conditions	Liver Fibroses, HBV (Hepatitis B Virus)
Enrollment	44 participants
Start Date	2025-09-01
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-08-28